FDA lays out digital health goals in 2018 strategic roadmap

OCT - digital therapeutics
Leveraging innovation and competition to better healthcare is one of the four cornerstones of the Food and Drug Administration’s 2018 policy roadmap
“The roadmap touches on several efforts to help develop medical devices, specifically the establishment of a Total Product Life Cycle Office within the Center for Devices and Radiological Health and the development of an alternative 510(k) pathway. FDA also plans to publish final guidance on what digital health technologies fall under FDA’s regulation and those that the agency plans to exercise enforcement discretion on. In December, the agency published a trio of documents that laid out its proposed thoughts on how it will approach its regulation of the space. The FDA chief acknowledged that modernizing how the agency regulates new areas such as digital health to ensure that the agency’s policies are suited to the new challenges. The plan pointed to enabling consumers to use new technologies, such as digital tools and medical apps, to make up-to-date decisions about their health.” Read the full article.
Check out this article and more on social media!

Related Posts

Solving the Top 3 Challenges Facing TPAs — How HealthAxis Empowers Modern Administration

The role of a third-party administrator (TPA) has never been more complex—or more critical. The global insurance third-party administrator market ...

Interoperability and Prior Authorization: A 2027 Perspective

The healthcare industry has long recognized the inefficiencies of prior authorization (PA) processes, which have historically been plagued by delays, ...

Reimagining Healthcare for 60 Years and Beyond

Reimagining Healthcare for 60 Years and Beyond  In 2025, HealthAxis proudly marks 60 years of innovation, resilience, and leadership in ...

Want To Know How We Can Help Your Organization?